rs1557235070
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_000052.7(ATP7A):c.2499-9T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000182 in 1,209,745 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000019 ( 0 hom. 8 hem. )
Consequence
ATP7A
NM_000052.7 intron
NM_000052.7 intron
Scores
2
Splicing: ADA: 0.000007944
2
Clinical Significance
Conservation
PhyloP100: -0.843
Publications
0 publications found
Genes affected
ATP7A (HGNC:869): (ATPase copper transporting alpha) This gene encodes a transmembrane protein that functions in copper transport across membranes. This protein is localized to the trans Golgi network, where it is predicted to supply copper to copper-dependent enzymes in the secretory pathway. It relocalizes to the plasma membrane under conditions of elevated extracellular copper, and functions in the efflux of copper from cells. Mutations in this gene are associated with Menkes disease, X-linked distal spinal muscular atrophy, and occipital horn syndrome. Alternatively-spliced transcript variants have been observed. [provided by RefSeq, Aug 2013]
PGK1 (HGNC:8896): (phosphoglycerate kinase 1) The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]
PGK1 Gene-Disease associations (from GenCC):
- glycogen storage disease due to phosphoglycerate kinase 1 deficiencyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant X-78015745-T-C is Benign according to our data. Variant chrX-78015745-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 533689.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 21 XL,AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATP7A | NM_000052.7 | c.2499-9T>C | intron_variant | Intron 11 of 22 | ENST00000341514.11 | NP_000043.4 | ||
| ATP7A | NM_001282224.2 | c.2265-9T>C | intron_variant | Intron 10 of 21 | NP_001269153.1 | |||
| ATP7A | NR_104109.2 | n.285-15655T>C | intron_variant | Intron 2 of 9 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ATP7A | ENST00000341514.11 | c.2499-9T>C | intron_variant | Intron 11 of 22 | 1 | NM_000052.7 | ENSP00000345728.6 |
Frequencies
GnomAD3 genomes AF: 0.00000893 AC: 1AN: 111988Hom.: 0 Cov.: 23 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
111988
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00000546 AC: 1AN: 183254 AF XY: 0.00 show subpopulations
GnomAD2 exomes
AF:
AC:
1
AN:
183254
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000191 AC: 21AN: 1097757Hom.: 0 Cov.: 30 AF XY: 0.0000220 AC XY: 8AN XY: 363171 show subpopulations
GnomAD4 exome
AF:
AC:
21
AN:
1097757
Hom.:
Cov.:
30
AF XY:
AC XY:
8
AN XY:
363171
show subpopulations
African (AFR)
AF:
AC:
0
AN:
26387
American (AMR)
AF:
AC:
0
AN:
35199
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19372
East Asian (EAS)
AF:
AC:
0
AN:
30170
South Asian (SAS)
AF:
AC:
0
AN:
54139
European-Finnish (FIN)
AF:
AC:
0
AN:
40494
Middle Eastern (MID)
AF:
AC:
0
AN:
4132
European-Non Finnish (NFE)
AF:
AC:
21
AN:
841788
Other (OTH)
AF:
AC:
0
AN:
46076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00000893 AC: 1AN: 111988Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34154 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
AF:
AC:
1
AN:
111988
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34154
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
0
AN:
30786
American (AMR)
AF:
AC:
0
AN:
10488
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2649
East Asian (EAS)
AF:
AC:
0
AN:
3568
South Asian (SAS)
AF:
AC:
0
AN:
2705
European-Finnish (FIN)
AF:
AC:
0
AN:
6123
Middle Eastern (MID)
AF:
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
AC:
1
AN:
53236
Other (OTH)
AF:
AC:
0
AN:
1511
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Menkes kinky-hair syndrome;C0268353:Cutis laxa, X-linked;C1845359:X-linked distal spinal muscular atrophy type 3 Benign:1
Dec 02, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.